Figures
Abstract
The ubiquitin-like modifier (UBL) domain of ubiquitin-like domain proteins (UDPs) interacts specifically with subunits of the 26 S proteasome. A novel UDP, ubiquitin-like domain-containing C-terminal domain phosphatase (UBLCP1), has been identified as an interacting partner of the 26 S proteasome. We determined the high-resolution solution structure of the UBL domain of human UBLCP1 by nuclear magnetic resonance spectroscopy. The UBL domain of hUBLCP1 has a unique β-strand (β3) and β3-α2 loop, instead of the canonical β4 observed in other UBL domains. The molecular topology and secondary structures are different from those of known UBL domains including that of fly UBLCP1. Data from backbone dynamics shows that the β3-α2 loop is relatively rigid although it might have intrinsic dynamic profile. The positively charged residues of the β3-α2 loop are involved in interacting with the C-terminal leucine-rich repeat-like domain of Rpn1.
Citation: Yun J-H, Ko S, Lee C-K, Cheong H-K, Cheong C, Yoon J-B, et al. (2013) Solution Structure and Rpn1 Interaction of the UBL Domain of Human RNA Polymerase II C-Terminal Domain Phosphatase. PLoS ONE 8(5): e62981. https://doi.org/10.1371/journal.pone.0062981
Editor: Annalisa Pastore, National Institute for Medical Research, Medical Research Council, United Kingdom
Received: May 12, 2012; Accepted: April 1, 2013; Published: May 7, 2013
Copyright: © 2013 Yun et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Korea Research Foundation Grant (KRF-2008-313-C00524 to W.L.), WCU (World Class University) program (R33-2009-000-10123-0) and High Field NMR Research Program of Korea Basic Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
An enzymatic cascade composed of the enzymes E1, E2, and E3 conjugates ubiquitin to target proteins, followed by translocation to the 26 S proteasome, where ubiquitinated protein is removed by proteolysis [1]. Despite low sequence homology, ubiquitin-like proteins are classified as ubiquitin-like modifiers (UBLs) and ubiquitin-like domain proteins (UDPs) [2]. UBLs, such as NEDD8, SUMO, and FAT10, modify target proteins in a manner similar to ubiquitinylation [3]. UDPs, including Rad23, the human homolog of Rad23 (HHR23), Dsk2, ubiquilins 1–4 (human homologs of Dsk2), and parkin, bind to the 26 S proteasome in a UBL domain-dependent manner [4], [5]. The UBL domain of UDPs interacts specifically with subunits of the 26 S proteasome. Rad23 and Dsk2 preferentially interact with the Rpn1/S2 subunit. UDPs have been implicated in neurodegenerative diseases caused by dysfunction of the ubiquitin proteasome system [6]. Recently, a novel UDP protein, ubiquitin-like domain-containing C-terminal domain phosphatase (UBLCP1) has been identified [7]. UBLCP1 consists of two independent domains, UBL and a phosphatase domain. It has been proposed that UBLCP1 directly interacts with Rpn1 of the 26 S proteasome through the UBL domain and that it serves as a transcription regulator via the phosphatase domain [8], [9], [10]. UBLCP1 also inhibits proteasome activity, dephosporylating the 26 S proteasome [10]. The crystal structure of Drosophila UBLCP1 shows that the UBL domain and the phosphatase domain are connected by a flexible linker and that the UBL domain has a β-grasp fold with four β-strands and two α-helices [10]. Because UBLCP1 has diverse functions related to regulation of the phosphorylation state of the 26 S proteasome, it is of the essence to understand the detailed interactions between UBLCP1 and Rpn1 of the proteasome component. We determined the solution structure of the UBL domain of human UBLCP1 (hUBLCP1). Structural information indicated detailed intermolecular interactions between the UBL domain and Rpn1 on the atomic scale. Nuclear magnetic resonance (NMR) data revealed that the secondary structure of the UBL domain of hUBLCP1 differs from that of known UBL domains, especially β3 and β4. In addition, the structure of the UBL domain of hUBLCP1 is dramatically different from that of the fly UBLCP1 [10]. Interestingly, the positively charged clamp formed by the unique β3-α2 loop of the UBL domain of hUBLCP1 serves as a key motif in the interaction with Rpn1.
Materials and Methods
Cloning, Expression, and Purification of Human UBLCP1 and Rpn1
Polymerase chain reaction (PCR) products of both hUBLCP1 and Rpn1 were amplified from a Homo sapiens cDNA library. All sense primers encoded the recognition site of tobacco etch virus protease (ENLYFQG) for the clearance of affinity tags. For both the UBLCP1 and UBL domain (UBLCP11–81), sense primers and antisense primers were designed as previously described [8], and amplified PCR products were ligated into the pGEX 4T-1 vector (Amersham Pharmacia Biotech, Uppsala, Sweden). The sense and antisense primers for three Rpn1 constructs, Rpn11–908, Rpn1394–568, and Rpn1640–772 incorporated BamHI and XhoI restriction enzyme sites, and PCR products were ligated into the pET32a vector. The plasmids were transformed into E. coli BL21 (DE3) cells for overexpression. The transformed cells were induced by 0.1 mM isopropyl β-D-thiogalactopyranoside at an OD600 of 0.6. All purified proteins were applied to a size exclusion chromatography column (Amersham Pharmacia Biotech) to improve protein purity and exchange the buffer solution.
Immunoprecipitation and in vitro GST Pull-down Assay
Cells were derived from HeLa Tet-Off (Clontech, Pala Alto, CA, USA) cells. EBNA-1 cells were transfected with pYR-HA-UBLCP1 and pYR-FLAG-RPN1. After 36 hours, cells were harvested and lysed in buffer solution consisting of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.2 mM phenylmethanesulfonyl fluoride, and 1.0% NP-40. The cell lysate was mixed with anti-FLAG or anti-hemagglutinin (HA) antibody-conjugated resin in 0.1% NP-40 for 4 hours at 4°C. Antibody resin was further washed with binding buffer containing 0.1% NP-40. The immune complexes were eluted in 20 mM Tris-HCl (pH 8.0) containing 2% sodium dodecyl sulfate. Immunoprecipitated proteins were detected using FLAG (Sigma, St Louis, MO, USA) and HA (Babco, Richmond, CA, USA) antibodies. The UBL domains (UBLCP11–81) of hUBLCP1, Rpn1 regulatory subunit 1 (Rpn1394–568), and Rpn1 regulatory subunit 2 (Rpn1640–772) were used for the pull-down assay. GST-fused UBLCP11–81 was loaded onto glutathione-Sepharose 4B resin and washed with lysis buffer. The TRX-His6-fused Rpn1394–568 and Rpn1640–772 were loaded onto the glutathione-Sepharose 4B resin preloaded with UBLCP11–81. After incubation for 1 hour at 25°C, the resin was washed and proteins were eluted using elution buffer containing 10 mM reduced glutathione. Samples were analyzed at each step by 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis.
NMR Spectroscopy and Structure Calculations
To obtain the 13C/15N- and 15N-labeled UBL domains of hUBLCP1, cells were cultured in M9 media containing 99% 15NH4Cl or 99% 15NH4Cl and 99% 13C-D-glucose (Cambridge Isotope Inc., Andover, MA, USA). Purified UBL domain was concentrated to 1.5 mM with an Amicon Ultra-15 concentration device (Millipore, Bedford, MA, USA). All NMR experiments were performed on Bruker DRX 500 MHz and Bruker Avance 900 MHz spectrometers equipped with a cryoprobe at 25°C. The 15N-edited two-dimensional (2D) HSQC, HNCACB, CBCA(CO)NH, HNCA, HNCO, HBHA(CO)NH, and HCCH-TOCSY experiments were performed for resonance assignments of backbone and side-chain atoms [11]. To obtain nuclear Overhauser effect (NOE) constraints for structure calculations, 15N-edited and 13C-edited three-dimensional (3D) NOESY experiments with two mixing times (τ = 100 and 150 ms) were performed. All NMR data were processed using NMRPipe [12] and analyzed using the SPARKY program. The in-phase-anti-phase (IPAP) experiment for residual dipolar coupling (RDC) measurements was performed using polyacrylamide gels prepared as described by Sass et al. [13]. The 6% polyacrylamide gels were made in a 5-mm inner-diameter tube, and dried after 3 days of dialysis. The 15N-labeled UBLCP11–81 (300 µl) was incorporated in the dried gel and placed in a Shigemi NMR tube, and the gel was compressed by the plunger. The 1DNH dipolar coupling constants in both isotropic and anisotropic media were measured using the 2D IPAP experiments [14] on the Bruker DRX 500 spectrometer. The RDC constants were calculated from the difference of the 1JNH splitting in isotropic and anisotropic media. The alignment tensor was calculated using REDCAT software [15].
NMR titration experiments for analysis of interaction of 15N-labeled UBLCP11–81 with Rpn1394–568 were conducted using a Bruker DRX 500 MHz equipped with a cryoprobe. Different molar ratios of UBLCP11–81 and Rpn1394–568 (1∶0.5, 1∶1, 1∶2) were used for the NMR titration [16]. The average values of the chemical shift changes were analyzed using the equation, △δAV = ((△δ1H)2+ (0.2×△δ15N)2)1/2. The symbols △δAV, △δ1H, and △δ15N designate average chemical shifts, 1H chemical shifts, and 15N chemical shift changes, respectively [17].
Structure calculations were performed using the CYANA 2.1 program [18] installed on a 16-node Linux cluster computer. The alignment tensor was used during the structure refinement procedure. From the RDC, Da and R values were calculated as 1.448±0.015 and 0.622±0.016, respectively. The value of the Q-factor after back calculations was determined as 0.34. A total of 2080 NOE constraints, consisting of 1009 short-range NOEs (|i–j| ≤1), 365 medium-range NOEs (1< |i–j| <5), 706 long-range NOEs (|i–j| ≥5), and 100 angle constraints were used for structure calculations [19]. The PROCHECK program was used for structure evaluation [20] and the MOLMOL, NACCESS, and Pymol programs were used for structural analyses [21].
Backbone Dynamics
Dynamics experiments were performed as previously described [22]. Longitudinal (T1) and transverse (T2) relaxation data for backbone amide protons were collected using different relaxation times, T1 = 0.05, 0.15, 0.3, 0.5, 0.7, 1, and 1.5 sec and T2 = 0.02, 0.04, 0.06, 0.08, 0.1, 0.12, and 0.14 sec. R1 and R2 decay rates were calculated using the exponential decay function in the CurveFit program (http://cpmcnet.columbia.edu/dept/gsas/biochem/labs/palmer/software/curvefit.html). The steady-state heteronuclear NOE (XNOE) experiments [22], [23] were performed using a relaxation delay of 3 sec, and XNOE values were calculated from peak heights of unsaturated and saturated NOE spectra using the equation σNOE/NOE = [(σIsat/Isat)2+(σIunsat/Iunsat)2]1/2. From the relaxation parameters, τm and rotational diffusion tensor were calculated. Order parameter (S2) and conformational exchange terms (Rex) were determined using the FASTModelfree program [24].
Isothermal Titration Calorimetry
VP-ITC system (MicroCal) was used for ITC experiments of UBL domain and Rpn1 regulatory subunit 1 at 25°C in NMR buffer. In each titration, 20 µM Rpn1 regulatory subunit 1 in the cell was titrated with 25 injections of 400 µM UBL domain. Each injection was 6 µL. The resulting data were fitted to a one-site binding isotherm using Microcal Origin program for ITC data analysis.
Results and Discussion
NMR Structures of the UBL Domain of hUBLCP1
All backbone resonance assignments were completed with data from HNCA, CBCACONH, and HNCACB experiments (Fig. 1A). Most of the side chain assignments were made based on 3D HCCH-TOCSY and 15N-edited TOCSY-HSQC experiments. Secondary structures were determined from the chemical shift indices (CSIs), NOEs, and 3JHNα coupling constant values.
(A) 1H-15N HSQC spectrum for the UBL domain was obtained using a Bruker DRX 900 MHz equipped with a cryoprobe. All backbone resonances in HSQC spectrum are labeled. (B) Molecular topology shows that the UBL domain of hUBLCP1 is composed of four β-strands and two α-helices. The unique β3-α2 loop exists in the same location in which β4 is usually found in the other UBLs. (C) The 20 lowest-energy structures were superimposed and fitted for the restraint energy minimization (REM) average structure using backbone atoms, Cα, N, and CO and the MOLMOL program. (D) Ribbon diagram shows molecular topology of the UBL domain generated by the Pymol program. The four β-strands and two α-helices are labeled on the structure.
The UBL domain of hUBLCP1 consisted of four short β-strands (β1, β2, β3, and β4) and two α-helices (α1 and α2) (Fig. 1B and Fig. S1). A total of 50 distance geometry structures were used as starting conformers for dynamical simulated annealing calculations. The structures were further refined using the calculated alignment tensor from the IPAP experiment. The 20 lowest-energy structures were selected for the final analysis (Table 1). The final structures were well converged, with a root-mean-square deviation (RMSD) of 0.44±0.13 Å and 0.74±0.11 Å for all backbone and heavy atoms, respectively (Fig. 1C). Especially, a unique β3-α2 loop was well defined by a number of intra-loop NOEs (Fig. 1D and Fig. S2) observed in that region. The average structure was calculated from the geometrical average of the 20 final structures and subjected to restraint energy minimization to correct covalent bonds and angle distortions (Fig. 1D).
Structural Comparison with other UBL Domains
The molecular topology of the UBL domain of hUBLCP1 was quite different from that of the canonical UBL domain (Fig. 1B), especially in the organization of the secondary structures (β3 and β4; Fig. 2A and Fig. 2B). The pairwise RMSDs of Cα of ubiquitin and the UBL domains of hHR23a, hPLIC-2, and parkin with respect to that of hUBLCP1 were 2.405 Å, 1.391 Å, 3.457 Å, and 3.785 Å, respectively. The fourth strand (β4) in the other UBLs was not observed in hUBLCP1; however, a unique β3-α2 loop was observed in that region (Fig. 1B and Fig. 2A). In addition, unlike other UBL domains, the UBL domain of hUBLCP1 has a short β3, comprising residues Q43, K44, and L45. Most of the unique β3-α2 loop in UBLCP11–81 is exposed to the solvent (Fig. 2B). Very recently, the crystal structure of dmUBLCP1 derived from Drosophila melanogaster was reported [10]. Although the UBL domain of dmUBLCP1 has a high percentage of sequence identity (54%) with that of human UBLCP1, dramatic differences between the two structures were observed (Fig. 2C, 2D, and 2E). Surprisingly, two α-helices (α1 and α2) are connected by a short linker in the UBL domain of the dmUBLCP1. This is very unusual because α2 is located far from α1 (next to β3/β4) in most of the UBL domains, including that of hUBLCP1 (Fig. 2A, 2B, and Fig. S1). However, the structural folds in the UBL domains of hUBLCP1 and dmUBLCP1 are very similar, consistent with the backbone RMSD between the two structures of 1.778 Å (Fig. 2D).
(A) Sequence alignment and secondary structures of the UBL domain of hUBLCP1, ubiquitin, hHR23a, hPLIC-2, and parkin. (B) Structural overlay of the β3-α2 loop of the UBL domain (red) of hUBLCP1 with that of ubiquitin (blue-white), hHR23a (pale cyan), hPLIC-2 (light blue), and Parkin (white-gray), respectively. (C) Sequence alignment and secondary structures of the UBL domains of human (hUBLCP1) and D. melanogaster (DmUBLCP1) UBLCP1. (D) Structural comparison of the UBL domains of human and D. melanogaster UBLCP1. (E) Superposition of the β3-α2 loop regions of the UBL domains of hUBLCP1 (red) and dmUBLCP1 (pale cyan).
Molecular Interaction between hUBLCP1 and Rpn1
Because the structure of the UBL domain of hUBLCP1 is unique, detailed analysis of Rpn1 binding is of the essence in understanding the mechanism underlying the interaction between the two molecules. Using an immunoprecipitation assay, we showed that hUBLCP1 directly interacts with the Rpn1 of the regulatory particle of the 26 S proteasome (Fig. 3A). A recent study suggests that leucine-rich repeat-like domains of Rpn1 recognize the ubiquitin motif [25]. Homology modeling and secondary structure predictions show that Rpn1 has two structural subunits, regulatory subunits 1 (Rpn1394–568) and 2 (Rpn1640–772) with leucine-rich repeat-like-rich sequences (data not shown). Data from the GST pull-down assay showed that regulatory subunit 1 (Rpn1394–568) directly interacts with UBLCP11–81, whereas regulatory subunit 2 (Rpn1640–772) of Rpn1 does not (Fig. 3B).
(A) Immunoprecipitation (IP) of both hUBLCP1 and Rpn1 was performed. Immunoblotting was conducted using HA- and FLAG-antibodies to distinguish the two proteins. IP was performed for the a-FLAG-RPN1 and co-precipitation was confirmed by IB. (B) In vitro GST pull-down assay using the GST-fused UBL domain of hUBLCP1 (UBLCP11–81), the TRX-His6-fused regulatory subunit 1 (Rpn1394–568), and subunit 2 (Rpn1640–772). Lane 1 (upper and lower), GST-fused UBL domain of UBLCP1; Lane 2 (upper), TRX-His6-fused Rpn1394–568 and (lower), TRX-His6-fused Rpn1640–772; Lane 3 (upper and lower), pull-down elution using GST elution buffer containing 10 mM reduced glutathione. (C) 15N-labeled UBL domain was titrated with Rpn1394–568. Superimposed 2D 1H-15N HSQC spectra of UBL domain without Rpn1394–568 (black) and with Rpn1394–568 (purple). To assess chemical shift perturbations of the UBL domain on Rpn1 binding, titration of 0–2 molar equivalents of Rpn1394–568 was performed. Residues K49 and A55 in the β3-α2 loop, K65 in the α2-β4 loop and W9 in the β1-β2 loop are displayed. (D) Chemical shift changes (△δ) of the UBL domain upon Rpn1394–568 binding are summarized. Chemical shift perturbations are shown by different colors: blue, 0 ppm<△δ ≤0.05 ppm; orange, 0.05 ppm<△δ ≤0.1 ppm; red, 0.1 ppm<△δ ≤ disappeared. Residues that "disappeared," due to peak broadening, are marked by asterisks and the secondary structures are also displayed. (E) Residues with significant chemical shift changes and less perturbed changes upon Rpn1 binding drawn by the Pymol program are shown by spheres and sticks, respectively. (F) Surface charge model of the UBL domain of the hUBLCP1. Electrostatic surfaces are shown for negative (red), positive (blue), and neutral (white) potential.
We performed NMR titration experiments to identify binding residues of the UBL domain of hUBLCP1 upon Rpn1 binding in solution. A number of chemical shift perturbations were observed upon Rpn1394–568 titration (Fig. 3C and 3D). Most of the resonance perturbations in the UBL domain of hUBLCP1 were found in the residues of the loop regions (i.e., W9, G11, T17, K49, K51, A55, and K65; Fig. 3E and 3F). Interestingly, K49, K51, and A55 in the β3-α2 loop are mainly involved in Rpn1 binding, which suggests the β3-α2 loop is responsible for Rpn1 binding. To determine the binding affinity of the UBL domain of hUBLCP1 for Rpn1394–568, we performed isothermal titration calorimetery experiments. The dissociation constant (Kd) and the enthalpy (ΔH) were calculated as 1.03×10−5±4.13×10−5 M and −5.38×10−4±8870 cal/mol, respectively.
Backbone Dynamics
Although the UBL domain of hUBLCP1 contains the canonical fold of UBL domains, the secondary structures and β3-α2 loop are very distinct. To correlate structure and dynamic properties of the UBL domain of hUBLCP1, we performed NMR backbone relaxation (Fig. 4A and 4B) and 15N-1H heteronuclear NOE experiments (Fig. 4C). The overall average R1, R2, and NOE values were determined as 2.44±0.13 s−1, 6.73±0.61 s−1, and 0.71±0.013, respectively. Interestingly, the average R1, R2, and XNOE values of the residues in the β3-α2 loops were determined as 2.36±0.139 s−1, 6.825±0.88 s−1, and 0.62, indicating that the β3-α2 loop is relatively rigid although it might have intrinsic dynamic profile. The order parameters and conformational exchange supported all dynamic data, with the average value of order parameters calculated as 0.861±0.037 (Fig. 4D). The conformational exchange parameters suggest an evidence of rapid exchange characteristics for some residues in the β3-α2 loop (Fig. 4E).
The values for (A) spin-lattice relaxation time (T1) and (B) spin-spin relaxation time (T2) are shown. (C) Heteronuclear NOE (XNOE) data are displayed. Error values were calculated using the following equation: σNOE/NOE = [(σIsat/Isat)2+ (σIunsat/Iunsat)2]1/2. (D) Calculated order parameter (S2) and (E) conformational exchange terms (Rex) are shown. All relaxation parameters were determined by the FASTModelfree program.
Functional Implications
Although UBLCP1 has been classified as a member of the UDP family, it is important to note that the UBL domain of hUBLCP1 has a unique structural feature, which could be related to its specific function. It is well known that UBLs recognize the ubiquitin-associated domain or ubiquitin-interacting motif through their conserved hydrophobic residues [26]. The hydrophobic residues in the β3-β4 loop and β5 of hPLIC-2, hHR23a, and parkin are mainly involved in molecular interactions with their partner proteins [27]–[29]. Our findings suggest that the UBL domain of hUBLCP1 interacts with regulatory subunit 1 of Rpn1 via hydrophilic residues of the unique β3-α2 loop. Therefore, we hypothesize that the unique structure of the UBL domain of hUBLCP1 could be responsible for specific recognition of partner molecules, such as Rpn1. Data from proteomics studies have suggested that the peptidase activity of individual subunits of the murine cardiac 20 S proteasome is enhanced by phosphorylation and that the activity is tightly regulated by protein phosphatase 2A and protein kinase A [30], [31]. The UBL domain of hUBLCP1 interacts with Rpn1 of the regulatory unit of the 26 S proteasome, and hUBLCP1 has been identified as one of the phosphatases functionally integrated with dephosphorylation of regulatory particles in the 26 S proteasome. Therefore, our findings will be directly applicable to future investigation of molecular interactions with the proteasome complex during regulation of the 26 S proteasome through posttranslational modification of regulatory particles.
Supporting Information
Figure S1.
A summary of NOE connectivity of the UBL domain of hUBLCP1. (A) Strips of NH-NH NOEs from 3D 15N-edited 3D NOESY-HSQC spectrum. Sequential and medium-range NOEs from L61 to L64 are indicative of α-helical structure. Sequential (dNN) and medium-range NOEs (dNN (i, i+2)) are marked by red and blue lines, respectively. (B) A Summary of NOE connectivity and secondary structures predicted by the CSI program. NOEs and consensus CSI values show that the UBL domain of hUBLCP1 consists of two α-helices and four β-strands.
https://doi.org/10.1371/journal.pone.0062981.s001
(TIF)
Figure S2.
Short and medium range NOEs for a unique β3-α2 loop region of the UBL domain of hUBLCP1. (A) Examples of NOE peaks from the 3D 15N-edited 3D NOESY-HSQC spectrum. Intra-residue and inter-residue NOEs are shown in blue and red, respectively. (B) A list of observed NOEs in the β3-α2 loop region. NOE intensities are classified as strong (s), medium (m) and weak (w).
https://doi.org/10.1371/journal.pone.0062981.s002
(TIF)
Author Contributions
Conceived and designed the experiments: WL JBY. Performed the experiments: SK JHY CC CKL HKC. Analyzed the data: SK JHY. Contributed reagents/materials/analysis tools: CC. Wrote the paper: JHY WL.
References
- 1. Ciechanover A (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17: 7151–7160.
- 2. Hartmann-Petersen R, Gordon C (2004) Integral UBL domain proteins: a family of proteasome interacting proteins. Semin Cell Dev Biol 15: 247–259.
- 3. Jentsch S, Pyrowolakis G (2000) Ubiquitin and its kin: how close are the family ties? Trends Cell Biol 10: 335–342.
- 4. Wilkinson CR, Seeger M, Hartmann-Petersen R, Stone M, Wallace M, et al. (2001) Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol 3: 939–943.
- 5. Schauber C, Chen L, Tongaonkar P, Vega I, Lambertson D, et al. (1998) Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 391: 715–718.
- 6. Lehman NL (2009) The ubiquitin proteasome system in neuropathology. Acta Neuropathol 118: 329–347.
- 7. Zheng H, Ji C, Gu S, Shi B, Wang J, et al. (2005) Cloning and characterization of a novel RNA polymerase II C-terminal domain phosphatase. Biochem Biophys Res Commun 331: 1401–1407.
- 8. Ko S, Lee Y, Yoon JB, Lee W (2009) Purification and NMR studies of RNA polymerase II C-terminal domain phosphatase 1 containing ubiquitin like domain. Bull Korean Chem Soc 30: 1039–1042.
- 9. Cho H, Kim TK, Mancebo H, Lane WS, Flores O, et al. (1999) A protein phosphatase functions to recycle RNA polymerase II. Genes Dev 13: 1540–1552.
- 10. Guo X, Engel JL, Xiao J, Tagliabracci VS, Wang X, et al. (2011) UBLCP1 is a 26 S proteasome phosphatase that regulates nuclear proteasome activity. Proc Natl Acad Sci 108: 18649–18654.
- 11. Grzesiek S, Dobeli H, Gentz R, Garotta G, Labhardt AM, et al. (1992) 1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma. Biochemistry 31: 8180–8190.
- 12. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277–293.
- 13. Sass HJ, Musco G, Stahl SJ, Wingfield PT, Grzesiek S, et al. (2000) Solution NMR of proteins within polyacrylamide gels: diffusional properties and residual alignment by mechanical stress or embedding of oriented purple membranes. J Biomol NMR 18: 303–309.
- 14. Ottiger M, Delaglio F, Bax A (1998) Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra. J Magn Res 131: 373–378.
- 15. Valafar H, Prestegard JH (2004) REDCAT: a residual dipolar coupling analysis tool. J Magn Res 167: 228–241.
- 16. Pervushin K, Riek R, Wider G, Wuthrich K (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci U S A 94: 12366–12371.
- 17. Ko S, Yu EY, Shin J, Yoo HH, Tanaka T, et al. (2009) Solution structure of the DNA binding domain of rice telomere binding protein RTBP1. Biochemistry 48: 827–838.
- 18. Guntert P (2004) Automated NMR structure calculation with CYANA. Methods Mol Biol 278: 353–378.
- 19. Cornilescu G, Delaglio F, Bax A (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13: 289–302.
- 20. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8: 477–486.
- 21.
Koradi R, Billeter M, Wuthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 51–55, 29–32.
- 22. Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, et al. (1994) Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33: 5984–6003.
- 23. Grzesiek S, Bax A (1993) The importance of not saturating H2O in protein NMR. Application to sensitivity enhancement and NOE measurements. J Am Chem Soc 115: 12593–12594.
- 24. Cole R, Loria JP (2003) FAST-Modelfree: A program for rapid automated analysis of solution NMR spin-relaxation data. J Biomol NMR 26: 203–213.
- 25. Elsasser S, Gali RR, Schwickart M, Larsen CN, Leggett DS, et al. (2002) Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nat Cell Biol 4: 725–730.
- 26. Hartmann-Petersen R, Gordon C (2004) Proteins interacting with the 26 S proteasome. Cell Mol Life Sci 61: 1589–1595.
- 27. Walters KJ, Kleijnen MF, Goh AM, Wagner G, Howley PM (2002) Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry 41: 1767–1777.
- 28. Mueller TD, Feigon J (2003) Structural determinants for the binding of ubiquitin-like domains to the proteasome. EMBO J 22: 4634–4645.
- 29. Sakata E, Yamaguchi Y, Kurimoto E, Kikuchi J, Yokoyama S, et al. (2003) Parkin binds the Rpn 10 subunit of 26 S proteasomes through its ubiquitin-like domain. EMBO Rep 4: 301–306.
- 30. Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, et al. (2006) Mapping the murine cardiac 26 S proteasome complexes. Circ Res 99: 362–371.
- 31. Zong C, Gomes AV, Drews O, Li X, Young GW, et al. (2006) Regulation of murine cardiac 20 S proteasomes: role of associating partners. Circ Res 99: 372–380.